arrow
M

Moriaki Inoko

the tazuke kofukai medical research institute
H指数:29
被引数:3,779

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Midterm outcomes after TAVR or SAVR in low-risk patients with severe aortic stenosis in the real clinical practice in Japan

日本真实临床实践中,低危重度主动脉瓣狭窄患者经导管主动脉瓣置换术或外科主动脉瓣置换术的中期结局

2026-08-120
PRE
Cardiac damage stages at follow-up and subsequent clinical outcomes in patients with severe aortic stenosis

随访期间严重主动脉瓣狭窄患者的心脏损伤阶段及后续临床结局

2026-05-260
PRE
Cardiac Damage Stages and Clinical Outcomes in Patients With Severe Aortic Stenosis
2026-01-011
OAAI
Real-world management and outcomes of venous thromboembolism in patients with cancer and limited life expectancy in the direct oral anticoagulant era: insights from the COMMAND VTE Registry-2

癌症伴有限制性预期寿命患者中静脉血栓栓塞的实际情况管理及结局:直接口服抗凝剂时代的见解——COMMAND VTE注册研究-2

2025-12-220
OAAI
Low-flow and normal-flow low-gradient aortic stenosis with reduced left ventricular ejection fraction. Insights from the CURRENT AS Registry-2

低血流和正常血流低梯度主动脉瓣狭窄伴左心室射血分数降低。CURRENT AS Registry-2注册研究的启示

2025-12-170
PRE
Validation of the 2018 Japanese Circulation Society (JCS)/ Japanese Heart Failure Society (JHFS) Guidelines for Preventing Sudden Cardiac Death in Patients With Hypertrophic Cardiomyopathy

2018年日本循环学会(JCS)/日本心力衰竭学会(JHFS)关于肥厚型心肌病患者预防 sudden cardiac death 指南的验证

2025-12-011
PRE
Low Body Weight and Long-term Outcomes in Patients with Venous Thromboembolism: Insights from the COMMAND VTE Registry-2

低体重和静脉血栓栓塞症患者长期预后:COMMAND VTE注册研究-2的见解

2025-12-011
PRE
Concomitant Antiplatelet Therapy in Patients With Venous Thromboembolism Treated With Anticoagulants ― Insights From the COMMAND VTE Registry-2 ―

静脉血栓栓塞症接受抗凝治疗的患者中联合抗血小板治疗——COMMAND VTE 注册研究-2 的见解——

2025-09-010
OAAI
Differences in Risk Factors between All-cause and PE-related Death in Acute Pulmonary Embolism: Insights from the COMMAND VTE Registry-2

急性肺栓塞中全因死亡与PE相关死亡风险因素的差异:COMMAND VTE注册研究-2的见解

2025-07-010
OAAI
Initial anticoagulation therapy with single direct oral anticoagulant in patients with intermediate-high risk acute pulmonary embolism: From the COMMAND VTE Registry-2
2025-01-011
PRE
Availability of transcatheter aortic valve implantation across hospitals and differences in strategies and clinical outcomes in patients with severe aortic stenosis

跨医院经导管主动脉瓣植入的可用性以及严重主动脉瓣狭窄患者的策略和临床结局的差异

2024-11-280
PRE
Concomitant Mitral Regurgitation in Severe Aortic Stenosis - Insights From the CURRENT AS Registry-2-

严重主动脉瓣狭窄伴二尖瓣反流-来自当前AS注册的见解-2-

2024-11-250
OA
Incidence and Risk factors of Early Mortality in Symptomatic Acute PE: Recent Insights from the COMMAND VTE Registry-2

症状性急性肺栓塞早期死亡的发生率及危险因素:COMMAND VTE Registry-2的最新见解

2024-11-120
PRE
Clinical characteristics and short-term outcomes of patients with critical acute pulmonary embolism requiring extracorporeal membrane oxygenation: from the COMMAND VTE Registry-2
2024-11-050
OAAI
Incidence and risk factors of ischemic stroke in patients with cancer-associated venous thromboembolism: from the Contemporary Management and Outcomes in Patients With Venous Thromboembolism Registry-2
2024-11-010
OAAI
Incidence of Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Embolism in the Era of Direct Oral Anticoagulants: From the COMMAND VTE Registry-2

直接口服抗凝剂时代肺栓塞后慢性血栓栓塞性肺动脉高压的发生率: 来自COMMAND VTE Registry-2

2024-10-221
OAAI
External validation of the Pulmonary Embolism-Syncope, Anemia, and Renal Dysfunction bleeding score for early major bleeding in patients with acute pulmonary embolism: from the COMMAND VTE Registry-2

急性肺栓塞患者早期大出血的肺栓塞-晕厥,贫血和肾功能不全出血评分的外部验证: 来自COMMAND VTE注册中心-2

2024-10-011
PRE
Selection of Home Treatment and Identification of Low-Risk Patients With Pulmonary Embolism Based on Simplified Pulmonary Embolism Severity Index Score in the Era of Direct Oral Anticoagulants
2024-10-010
OAAI